首页> 外文期刊>Toxicology Letters: An International Journal Providing a Forum for Original and Pertinent Contributions in Toxicology Research >Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
【24h】

Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.

机译:安全药理学:新药的非临床评估中药理学和毒理学的基本界面。

获取原文
获取原文并翻译 | 示例
           

摘要

Safety pharmacology studies are defined as the studies that investigate the potential undesirable pharmacodynamic effects of a substance on physiological functions in relation to exposure. In consequence, these studies are an integral part of the non-clinical safety assessment of new pharmaceuticals, in association with toxicological studies. A retrospective shows the evolution of the discipline in these last years. Safety pharmacology studies are of special interest, and some drawbacks and pitfalls must be considered (i.e. invasive methods, difficulties related to GLP (good laboratory practices) requirements, choice of a strategy). In the future, some priority should be given to education, promotion of scientific activities, reinforcement of the links between pharmacologists and toxicologists and implementation of relevant guidelines.
机译:安全药理学研究定义为研究物质对与暴露有关的生理功能的潜在不良药效作用的研究。因此,这些研究与毒理学研究一起是新药非临床安全性评估的组成部分。回顾展显示了最近几年该学科的发展。安全药理学研究特别受到关注,并且必须考虑一些缺点和陷阱(即侵入性方法,与GLP(良好实验室规范)要求有关的困难,策略的选择)。将来,应优先考虑教育,促进科学活动,加强药理学家和毒理学家之间的联系以及执行相关准则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号